Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin

UCSF Chimera—A visualization system for exploratory research and analysis

Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,260 · see citing works

The PyMOL Molecular Graphics System

DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147 · see citing works

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160 · see citing works

A genome-wide association study identifies novel risk loci for type 2 diabetes

Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993 · see citing works

Handbook of Proteolytic Enzymes

(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,627 · see citing works

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849 · see citing works

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,488 · see citing works

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431 · see citing works

Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · see citing works

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E., Frosch, M., Eckman, C., Tanzi, R., Selkoe, D., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0230450100 · Cited by 1,361 · see citing works

THE UBIQUITIN 26S PROTEASOME PROTEOLYTIC PATHWAY

Smalle, J., & Vierstra, R. D. (2004) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.55.031903.141801 · Cited by 1,350 · see citing works

Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease

Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987 · see citing works

Detection, delineation, measurement and display of cavities in macromolecular structures

Kleywegt, G. J., & Jones, T. A. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444993011333 · Cited by 972 · see citing works

Metabolic Regulation of Brain Aβ by Neprilysin

Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N., Gerard, C., Hama, E., Lee, H., & Saido, T. (2001) · Science · doi:10.1126/science.1059946 · Cited by 894 · see citing works

Insulin Degradation: Progress and Potential

Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 875 · see citing works

Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition

Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867 · see citing works

Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation

Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812 · see citing works

Families of zinc metalloproteases

Hooper, N. M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01079-x · Cited by 790 · see citing works

Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.

Roques, B. P., Noble, F., Daugé, V., Fournié‐Zaluski, M., & Beaumont, A. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00449-1 · Cited by 754 · see citing works

Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., & Du Yan, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3735fje · Cited by 738 · see citing works

Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death

Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 708 · see citing works

The HtrA Family of Proteases

Clausen, T., Southan, C., & Ehrmann, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00658-5 · Cited by 640 · see citing works

Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo

Bateman, R. J., Munsell, L. Y., Morris, J. C., Swarm, R., Yarasheski, K. E., & Holtzman, D. M. (2006) · Nature Medicine · doi:10.1038/nm1438 · Cited by 599 · see citing works

Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's Disease

DeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M., & Holtzman, D. M. (2002) · Science · doi:10.1126/science.1067568 · Cited by 563 · see citing works

Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis

Qiu, W. Q., & Folstein, M. F. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.004 · Cited by 538 · see citing works

Neurons Regulate Extracellular Levels of Amyloid β-Protein via Proteolysis by Insulin-Degrading Enzyme

Vekrellis, K., Ye, Z., Qiu, W. Q., Walsh, D. M., Hartley, D. M., Chesneau, V., Rosner, M. R., & Selkoe, D. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01657.2000 · Cited by 495 · see citing works

Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene

Yanagisawa, H., Yanagisawa, M., Kapur, R. P., Richardson, J. A., Williams, S. C., Clouthier, D. E., de Wit, D., Emoto, N., & Hammer, R. E. (1998) · Development · doi:10.1242/dev.125.5.825 · Cited by 490 · see citing works

Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy

Bacskai, B. J., Kajdasz, S. T., Christie, R. H., Carter, C., Games, D., Seubert, P. A., Schenk, D., & Hyman, B. T. (2001) · Nature Medicine · doi:10.1038/85525 · Cited by 445 · see citing works

Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

Kurochkin, I. V., & Goto, S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00387-4 · Cited by 401 · see citing works

Neprilysin Gene Transfer Reduces Human Amyloid Pathology in Transgenic Mice

Marr, R. A., Rockenstein, E. M., Mukherjee, A., Kindy, M. S., Hersh, L. B., Gage, F. H., Verma, I. M., & Masliah, E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-01992.2003 · Cited by 391 · see citing works

Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism

Shen, Y., Joachimiak, A., Rosner, M. R., & Tang, W. (2006) · Nature · doi:10.1038/nature05143 · Cited by 375 · see citing works

A Critical Function for β-Amyloid Precursor Protein in Neuronal Migration Revealed by <i>In Utero</i> RNA Interference

Young-Pearse, T. L., Bai, J., Chang, R., Zheng, J. B., LoTurco, J. J., & Selkoe, D. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4701-07.2007 · Cited by 369 · see citing works

Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide

Yasojima, K., Akiyama, H., McGeer, E. G., & McGeer, P. L. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01675-x · Cited by 357 · see citing works

Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-β<i>In Vivo</i>by Immunotherapy

Bacskai, B. J., Kajdasz, S. T., McLellan, M. E., Games, D., Seubert, P., Schenk, D., & Hyman, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07873.2002 · Cited by 323 · see citing works

Neprilysin Degrades Both Amyloid β Peptides 1–40 and 1–42 Most Rapidly and Efficiently among Thiorphan- and Phosphoramidon-sensitive Endopeptidases

Shirotani, K., Tsubuki, S., Iwata, N., Takaki, Y., Yamao‐Harigaya, W., Maruyama, K., Kiryu‐Seo, S., Kiyama, H., Iwata, H., Tomita, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008511200 · Cited by 312 · see citing works

Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels <i>in vivo</i>

Miller, B. C., Eckman, E. A., Sambamurti, K., Dobbs, N., Chow, K. M., Eckman, C. B., Hersh, L. B., & Thiele, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031520100 · Cited by 294 · see citing works

Physiological roles for amyloid β peptides

Pearson, H. A., & Peers, C. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.111203 · Cited by 286 · see citing works

Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon 1 1Edited by R. Huber

Oefner, C., D'Arcy, A., Hennig, M., Winkler, F. K., & Dale, G. E. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3492 · Cited by 282 · see citing works

Partial Loss-of-Function Mutations in Insulin-Degrading Enzyme that Induce Diabetes also Impair Degradation of Amyloid β-Protein

Farris, W., Mansourian, S., Leissring, M. A., Eckman, E. A., Bertram, L., Eckman, C. B., Tanzi, R. E., & Selkoe, D. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63229-4 · Cited by 269 · see citing works

Insulin increases CSF Aβ42 levels in normal older adults

Watson, G. S., Peskind, E. R., Asthana, S., Purganan, K., Wait, C., Chapman, D., Schwartz, M. W., Plymate, S. R., & Craft, S. (2003) · Neurology · doi:10.1212/01.wnl.0000065916.25128.25 · Cited by 265 · see citing works

Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme

Eckman, E. A., Watson, M., Marlow, L. A., Sambamurti, K., & Eckman, C. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200642200 · Cited by 263 · see citing works

Structure of insulin in 4-zinc insulin

Bentley, G. A., Dodson, E. J., Dodson, G. G., Hodgkin, D. C., & Mercola, D. (1976) · Nature · doi:10.1038/261166a0 · Cited by 256 · see citing works

Crystal Structures of Mitochondrial Processing Peptidase Reveal the Mode for Specific Cleavage of Import Signal Sequences

Taylor, A. B., Smith, B. S., Kitada, S., Kojima, K., Miyaura, H., Otwinowski, Z., Ito, A., & Deisenhofer, J. (2001) · Structure · doi:10.1016/s0969-2126(01)00621-9 · Cited by 246 · see citing works

Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain

Yasojima, K., McGeer, E. G., & McGeer, P. L. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03008-6 · Cited by 224 · see citing works

Degradation of the Amyloid β-Protein by the Novel Mitochondrial Peptidasome, PreP

Falkevall, A., Alikhani, N., Bhushan, S., Pavlov, P. F., Busch, K., Johnson, K. A., Eneqvist, T., Tjernberg, L. O., Ankarcrona, M., & Glaser, E. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602532200 · Cited by 202 · see citing works

Electrostatic steering and ionic tethering in enzyme–ligand binding: Insights from simulations

Wade, R. C., Gabdoulline, R. R., Lüdemann, S. K., & Lounnas, V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5942 · Cited by 200 · see citing works

Regulation of Steady-state β-Amyloid Levels in the Brain by Neprilysin and Endothelin-converting Enzyme but Not Angiotensin-converting Enzyme

Eckman, E. A., Adams, S. K., Troendle, F. J., Stodola, B. A., Kahn, M. A., Fauq, A. H., Xiao, H. D., Bernstein, K. E., & Eckman, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605827200 · Cited by 196 · see citing works

Insulin-degrading enzyme: embarking on amyloid destruction

Kurochkin, I. V. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01876-x · Cited by 178 · see citing works

Structure and Function of HtrA Family Proteins, the Key Players in Protein Quality Control

Kim, D. Y., & Kim, K.-K. (2005) · BMB Reports · doi:10.5483/bmbrep.2005.38.3.266 · Cited by 171 · see citing works

Degradation of Amylin by Insulin-degrading Enzyme

Bennett, R. G., Duckworth, W. C., & Hamel, F. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006170200 · Cited by 170 · see citing works

Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria

Leissring, M. A., Farris, W., Wu, X., Christodoulou, D. C., Haigis, M. C., Guarente, L., & Selkoe, D. J. (2004) · Biochemical Journal · doi:10.1042/bj20041081 · Cited by 162 · see citing works

Insulin Degrading Enzyme Is a Cellular Receptor Mediating Varicella-Zoster Virus Infection and Cell-to-Cell Spread

Li, Q., Ali, M. A., & Cohen, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.08.046 · Cited by 154 · see citing works

Human Insulin-Degrading Enzyme Shares Structural and Functional Homologies with E. coli Protease III

Affholter, J. A., Fried, V. A., & Roth, R. A. (1988) · Science · doi:10.1126/science.3059494 · Cited by 148 · see citing works

Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study

Cooke, R. M., Harvey, T. S., & Campbell, I. D. (1991) · Biochemistry · doi:10.1021/bi00236a022 · Cited by 143 · see citing works

Isolation and Identification of a Novel Mitochondrial Metalloprotease (PreP) That Degrades Targeting Presequences in Plants

Ståhl, A.-L., Moberg, P., Ytterberg, J., Panfilov, O., von Löwenhielm, H. B., Nilsson, F. Y., & Glaser, E. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205500200 · Cited by 135 · see citing works

Characterization of a novel zinc metalloprotease involved in degrading targeting peptides in mitochondria and chloroplasts

Moberg, P., Ståhl, A.-L., Bhushan, S., Wright, S. J., Eriksson, A., Bruce, B. D., & Glaser, E. G. (2003) · The Plant Journal · doi:10.1046/j.1365-313x.2003.01904.x · Cited by 122 · see citing works

Reducing Amyloid Plaque Burden via Ex Vivo Gene Delivery of an Aβ-Degrading Protease: A Novel Therapeutic Approach to Alzheimer Disease

Hemming, M. L., Patterson, M., Reske-Nielsen, C., Lin, L., Ole Isacson, A., & Selkoe, D. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040262 · Cited by 119 · see citing works

The closed structure of presequence protease PreP forms a unique 10 000 Å3 chamber for proteolysis

Johnson, K. A., Bhushan, S., Ståhl, A.-L., Hällberg, B. M., Frohn, A., Glaser, E. G., & Eneqvist, T. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601080 · Cited by 104 · see citing works

Neprylisin decreases uniformly in Alzheimer's disease and in normal aging

Russo, R., Borghi, R., Markesbery, W. R., Tabaton, M., & Piccini, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.054 · Cited by 87 · see citing works

Alternative Splicing of Human Insulin-Degrading Enzyme Yields a Novel Isoform with a Decreased Ability To Degrade Insulin and Amyloid β-Protein

Farris, W., Leissring, M. A., Hemming, M. L., Chang, A. Y., & Selkoe, D. J. (2005) · Biochemistry · doi:10.1021/bi0476578 · Cited by 87 · see citing works

Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease

Hamaguchi, T., Ono, K., & Yamada, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5599-9 · Cited by 82 · see citing works

Structural analysis of neprilysin with various specific and potent inhibitors

Oefner, C., Roques, B. P., Fournie-Zaluski, M.-C., & Dale, G. E. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903027410 · Cited by 81 · see citing works

Amyloidogenic determinant as a substrate recognition motif of insulin‐degrading enzyme

Kurochkin, I. V. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00422-0 · Cited by 79 · see citing works

Two Novel Targeting Peptide Degrading Proteases, PrePs, in Mitochondria and Chloroplasts, so Similar and Still Different

Ståhl, A.-L., Nilsson, S., Lundberg, P., Bhushan, S., Biverstål, H., Moberg, P., Morisset, M., Vener, A. V., Mäler, L., Langel, Ü., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.04.023 · Cited by 78 · see citing works

Structural Determinants of Natriuretic Peptide Receptor Specificity and Degeneracy

He, X. L., Dukkipati, A., & García, K. C. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.060 · Cited by 76 · see citing works

Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry

Mueller, D., Schulze, C., Baumeister, H., Buck, F., & Richter, D. (1992) · Biochemistry · doi:10.1021/bi00160a026 · Cited by 74 · see citing works

Differential Effects of Proteases Involved in Intracellular Degradation of Amyloid β-Protein between Detergent-Soluble and -Insoluble Pools in CHO-695 Cells

Sudoh, S., Frosch, M. P., & Wolf, B. A. (2002) · Biochemistry · doi:10.1021/bi011193l · Cited by 73 · see citing works

Atrial natriuretic peptide (ANP) is a high‐affinity substrate for rat insulin‐degrading enzyme

Müller, D., Baumeister, H., Buck, F., & Richter, D. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16374.x · Cited by 72 · see citing works

New Insights into the Roles of Metalloproteinases in Neurodegeneration and Neuroprotection

Turner, A. J., & Nalivaeva, N. N. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82006-x · Cited by 70 · see citing works

Aβ42-induced Increase in Neprilysin Is Associated with Prevention of Amyloid Plaque Formation in Vivo

Mohajeri, M. H., Wollmer, M. A., & Nitsch, R. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202899200 · Cited by 66 · see citing works

Solution structure of human insulin-like growthfactor II. Relationship to receptor and binding protein interactions

Torres, A. M., Forbes, B. E., Aplin, S. E., Wallace, J. C., Francise, G. L., & Norton, R. S. (1995) · Journal of Molecular Biology · doi:10.1016/s0022-2836(95)80058-1 · Cited by 65 · see citing works

The inactivation of insulin by tissue extracts; the effect of fasting on the insulinase content of rat liver.

Broh-Kahn, R. H., & MIRSKY, I. A. (1949) · PubMed · Cited by 58 · see citing works

Characterization of Endothelin-converting Enzyme-2

Mzhavia, N., Pan, H., Che, F., Fricker, L. D., & Devi, L. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211242200 · Cited by 55 · see citing works

The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition

Li, P., Kuo, W., Yousef, M., Rosner, M. R., & Tang, W. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.083 · Cited by 54 · see citing works

Specificity of mechanisms for plaque removal after Aβ immunotherapy for Alzheimer disease

Akiyama, H., & McGeer, P. L. (2004) · Nature Medicine · doi:10.1038/nm0204-117 · Cited by 51 · see citing works

Degradation Of Insulin-Like Growth Factors I And II By A Human Insulin Degrading Enzyme

Roth, R. A., Mesirow, M. L., Yokono, K., & Baba, S. (1984) · Endocrine Research · doi:10.3109/07435808409035411 · Cited by 51 · see citing works

Constitutive Lysosomal Targeting and Degradation of Bovine Endothelin-converting Enzyme-1a Mediated by Novel Signals in Its Alternatively Spliced Cytoplasmic Tail

Emoto, N., Nurhantari, Y., Alimsardjono, H., Xie, J., Yamada, T., Yanagisawa, M., & Matsuo, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1509 · Cited by 50 · see citing works

Functional Human Insulin-Degrading Enzyme Can Be Expressed in Bacteria

Chesneau, V., & Rosner, M. R. (2000) · Protein Expression and Purification · doi:10.1006/prep.2000.1217 · Cited by 47 · see citing works

Proteolytic Degradation of Alzheimer's Disease Amyloid β‐Peptide by a Metalloproteinase from Microglia Cells

Mentlein, R., Ludwig, R., & Martensen, I. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020721.x · Cited by 45 · see citing works

Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV

Oefner, C., Pierau, S., Schulz, H., & Dale, G. E. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444907036281 · Cited by 43 · see citing works

Structural Basis for Type II Membrane Protein Binding by ERM Proteins Revealed by the Radixin-neutral Endopeptidase 24.11 (NEP) Complex

Terawaki, S., Kitano, K., & Hakoshima, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609232200 · Cited by 42 · see citing works

Ubiquitin-proteasome system

Hartmann‐Petersen, R., & Gordon, C. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4132-x · Cited by 39 · see citing works

Direct Binding of Neutral Endopeptidase 24.11 to Ezrin/Radixin/Moesin (ERM) Proteins Competes with the Interaction of CD44 with ERM Proteins

Iwase, A., Shen, R., Navarro, D., & Nanus, D. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m212737200 · Cited by 39 · see citing works

INHIBITION OF INSULIN DEGRADATION BY INSULIN-LIKE GROWTH FACTORS

Misbin, R. I., Almira, E. C., Duckworth, W. C., & Mehl, T. D. (1983) · Endocrinology · doi:10.1210/endo-113-4-1525 · Cited by 36 · see citing works

Degradation of Insulin and Insulin-Like Growth Factors by Enzyme Purified From Human Erythrocytes: Comparison of Degradation Products Observed With A14- and B26-[125I]monoiodoinsulin

Misbin, R. I., & Almira, E. C. (1989) · Diabetes · doi:10.2337/diab.38.2.152 · Cited by 33 · see citing works

A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP)

Bur, D., Dale, G. E., & Oefner, C. (2001) · Protein Engineering Design and Selection · doi:10.1093/protein/14.5.337 · Cited by 29 · see citing works

Enzyme target to latch on to

Leissring, M. A., & Selkoe, D. J. (2006) · Nature · doi:10.1038/nature05210 · Cited by 25 · see citing works

solution Conformation of an Atrial Natriuretic Peptide Variant Selective for the Type A Receptor

Fairbrother, W. J., McDowell, R. S., & Cunningham, B. C. (1994) · Biochemistry · doi:10.1021/bi00196a006 · Cited by 23 · see citing works

Effect of 'Insulinase-Inhibitor' on Destruction of Insulin by Intact Mouse.

Mirsky, I. A., Perisutti, G., & DIENGOTT, D. (1955) · Experimental Biology and Medicine · doi:10.3181/00379727-88-21497 · Cited by 13 · see citing works

NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice

Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · see citing works

&lt;p&gt;Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics&lt;/p&gt;

Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200490 · Cited by 1,308 · see citing works

The role of microglia in amyloid clearance from the AD brain

Lee, C. Y. D., & Landreth, G. E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0433-4 · Cited by 701 · see citing works

Is Alzheimer’s disease a type 3 diabetes? A critical appraisal

Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621 · see citing works

Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process

De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455 · see citing works

IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline

Fu, A. K. Y., Hung, K.-W., Yuen, M. Y. F., Zhou, X., Mak, D. S. Y., Chan, I. C. W., Cheung, T. H., Zhang, B., Fu, W.-Y., Liew, F. Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604032113 · Cited by 369 · see citing works

Natriuretic peptide metabolism, clearance and degradation

Potter, L. R. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08082.x · Cited by 359 · see citing works

Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease

Baranello, R., Bharani, K., Padmaraju, V., Chopra, N., Lahiri, D., Greig, N., Pappolla, M., & Sambamurti, K. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666141218140953 · Cited by 331 · see citing works

Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer’s Disease

Ding, M., Shen, Y., Wang, P., Xie, Z., Xu, S., Zhu, Z., Wang, Y., Lyu, Y., Dewei, W., Xu, L., et al. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2641-5 · Cited by 279 · see citing works

Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones

Maianti, J. P., McFedries, A., Foda, Z. H., Kleiner, R. E., Du, X. Q., Leissring, M. A., Tang, W., Charron, M. J., Seeliger, M. A., Saghatelian, A., et al. (2014) · Nature · doi:10.1038/nature13297 · Cited by 251 · see citing works

Mitochondrial sirtuins

Huang, J.-Y., Hirschey, M. D., Shimazu, T., Ho, L., & Verdin, E. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.12.021 · Cited by 231 · see citing works

Peroxisomes in brain development and function

Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194 · see citing works

Are amyloid‐degrading enzymes viable therapeutic targets in Alzheimer’s disease?

Nalivaeva, N., Beckett, C. S., Belyaev, N. D., & Turner, A. J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07510.x · Cited by 178 · see citing works

Pathological role of hypoxia in Alzheimer's disease

Zhang, X., & Le, W. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.033 · Cited by 189 · see citing works

Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease

Kurochkin, I. V., Guarnera, E., & Berezovsky, I. N. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.10.008 · Cited by 185 · see citing works

Toward a comprehensive neurobiology of IGF‐I

Torres‐Alemán, I. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20778 · Cited by 177 · see citing works

Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model

Yang, H., Xie, Z., Wei, L. F., Yang, H. N., Yang, S. N., Zhu, Z., Wang, P., Zhao, C., & Bi, J. Z. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt227 · Cited by 166 · see citing works

Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme

Zhang, Z., Liang, W. G., Bailey, L. J., Tan, Y. Z., Wei, H., Wang, A., Farcasanu, M., Woods, V. A., McCord, L. A., Lee, D. E., et al. (2018) · eLife · doi:10.7554/elife.33572 · Cited by 148 · see citing works

Transthyretin Protects against A-Beta Peptide Toxicity by Proteolytic Cleavage of the Peptide: A Mechanism Sensitive to the Kunitz Protease Inhibitor

Costa, A. R., Ferreira‐da‐Silva, F., Saraiva, M. J., & Cardoso, I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002899 · Cited by 126 · see citing works

Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus

Tang, W. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.11.003 · Cited by 120 · see citing works

Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice

Tzeng, T.-T., Chen, C., Lee, L., Wan-Ping, C., Chung-Kuang, L., Shen, C., Chi-Ying, H. F., Chien-Chih, C., & Shiao, Y. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0266-z · Cited by 122 · see citing works

The storm before the quiet: neuronal hyperactivity and aβ in the presymptomatic stages of Alzheimer’s disease

Stargardt, A., Swaab, D. F., & Bossers, K. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.014 · Cited by 109 · see citing works

Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin

Leissring, M. A., Malito, E., Hédouin, S., Reinstatler, L. S., Sahara, T., Abdul‐Hay, S. O., Choudhry, S., Maharvi, G. M., Fauq, A. H., Huzarska, M. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010504 · Cited by 108 · see citing works

Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme

Manolopoulou, M., Guo, Q., Malito, E., Schilling, A. B., & Tang, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900068200 · Cited by 108 · see citing works

Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP 3 inflammasome activation in APP / PS 1 transgenic mice

Feng, J., Wang, J., Du, Y., Liu, Y., Zhang, W., Chen, J., Liu, Y., Zheng, M., Wang, K., & He, G. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12983 · Cited by 108 · see citing works

Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice

Deprez-Poulain, R. F., Hennuyer, N., Bosc, D., Liang, W. G., Waeckel-Énée, E., Marechal, X., Charton, J., Totobenazara, J., Berte, G., Jahklal, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9250 · Cited by 97 · see citing works

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease

Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 95 · see citing works

Inflammasome-mediated innate immunity in Alzheimer’s disease

Venegas, C., & Heneka, M. T. (2019) · The FASEB Journal · doi:10.1096/fj.201900439 · Cited by 93 · see citing works

Insulin-degrading enzyme is exported via an unconventional protein secretion pathway

Zhao, J., Li, L., & Leissring, M. A. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-4 · Cited by 90 · see citing works

Molecular Basis for the Recognition and Cleavages of IGF-II, TGF-α, and Amylin by Human Insulin-Degrading Enzyme

Guo, Q., Manolopoulou, M., Bian, Y., Schilling, A. B., & Tang, W. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.072 · Cited by 87 · see citing works

Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer’s Disease Biology: Characterization of Putative Cognates for Therapeutic Applications

Jha, N. K., Jha, S. K., Kumar, D., Kejriwal, N., Sharma, R., Ambasta, R. K., & Kumar, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150379 · Cited by 88 · see citing works

Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading Enzyme

Malito, E., Ralat, L. A., Manolopoulou, M., Tsay, J. L., Wadlington, N. L., & Tang, W. (2008) · Biochemistry · doi:10.1021/bi801192h · Cited by 84 · see citing works

Insulin-degrading Enzyme Modulates the Natriuretic Peptide-mediated Signaling Response

Ralat, L. A., Guo, Q., Ren, M., Funke, T., Dickey, D. M., Potter, L. R., & Tang, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173252 · Cited by 78 · see citing works

Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening

Cabrol, C., Huzarska, M. A., Dinolfo, C., Rodríguez, M. C., Reinstatler, L. S., Ni, J., Yeh, L.-A., Cuny, G. D., Stein, R. L., Selkoe, D. J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005274 · Cited by 77 · see citing works

The effect of cognitive-motor dual-task training on cognitive function and plasma amyloid β peptide 42/40 ratio in healthy elderly persons: a randomized controlled trial

Yokoyama, H., Okazaki, K., Imai, D., Yamashina, Y., Takeda, R., Naghavi, N., Ota, A., Hirasawa, Y., & Miyagawa, T. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0058-4 · Cited by 76 · see citing works

Long-Term Treatment of Thalidomide Ameliorates Amyloid-Like Pathology through Inhibition of β-Secretase in a Mouse Model of Alzheimer’s Disease

He, P., Cheng, X., Staufenbiel, M., Li, R.-N., & Shen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055091 · Cited by 69 · see citing works

Engineering Neprilysin Activity and Specificity to Create a Novel Therapeutic for Alzheimer’s Disease

Webster, C. I., Burrell, M. R., Olsson, L., Fowler, S. A., Digby, S., Sandercock, A. M., Snijder, A., Tebbe, J., Haupts, U. M., Grudzinska, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104001 · Cited by 73 · see citing works

Copper(I) and Copper(II) Inhibit Aβ Peptides Proteolysis by Insulin‐Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer’s Disease

Grasso, G., Pietropaolo, A., Spoto, G., Pappalardo, G., Tundo, G. R., Ciaccio, C., Coletta, M., & Rizzarelli, E. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201002809 · Cited by 72 · see citing works

Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme

McCord, L. A., Liang, W. G., Dowdell, E., Kalas, V., Hoey, R. J., Koide, A., Koide, S., & Tang, W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304575110 · Cited by 73 · see citing works

Protease Regulation: The Yin and Yang of Neural Development and Disease

Bai, G., & Pfaff, S. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.012 · Cited by 70 · see citing works

Amyloid-β Peptide Is a Substrate of the Human 20S Proteasome

Zhao, X., & Yang, J. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100067e · Cited by 68 · see citing works

Chapter 22 Structure, Function, and Regulation of Insulin‐Degrading Enzyme

Hulse, R. E., Ralat, L. A., & Wei‐Jen, T. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00622-5 · Cited by 69 · see citing works

Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease

Kim, N., & Lee, H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147697 · Cited by 67 · see citing works

Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease

Pardeshi, R., Bolshette, N. B., Gadhave, K., Ahire, A., Ahmed, S., Cassano, T., Gupta, V. B., & Lahkar, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.004 · Cited by 65 · see citing works

Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases

Sousa, L., Guarda, M., Meneses, M. J., Macedo, M. P., & Miranda, H. V. (2021) · The Journal of Pathology · doi:10.1002/path.5777 · Cited by 63 · see citing works

Molecular Basis of Substrate Recognition and Degradation by Human Presequence Protease

King, J. V. L., Liang, W. G., Scherpelz, K. P., Schilling, A. B., Meredith, S. C., & Tang, W. (2014) · Structure · doi:10.1016/j.str.2014.05.003 · Cited by 60 · see citing works

Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme

Maianti, J. P., Tan, G. A., Vetere, A., Welsh, A. J., Wagner, B. K., Seeliger, M. A., & Liu, D. R. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0271-0 · Cited by 58 · see citing works

Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo

Durham, T. B., Toth, J. L., Klimkowski, V. J., Cao, J. X. C., Siesky, A. M., Alexander-Chacko, J. T., Wu, G. Y., Dixon, J. T., McGee, J. E., Wang, Y., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638205 · Cited by 51 · see citing works

Comparison between the digestive behaviors of a new in vitro rat soft stomach model with that of the in vivo experimentation on living rats – Motility and morphological influences

Chen, L., Wu, X., & Chen, X. D. (2013) · Journal of Food Engineering · doi:10.1016/j.jfoodeng.2013.02.003 · Cited by 50 · see citing works

Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer’s Disease

Gupta, S. N., Yadav, K., Mantri, S. S., Singhal, N. K., Ganesh, S., & Sandhir, R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0985-0 · Cited by 46 · see citing works

SGLT2 and DPP4 inhibitors improve Alzheimer’s disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse model

Sim, A. Y., Choi, D. H., Kim, J. Y., Kim, E. R., Goh, A. R., Lee, Y., & Lee, J. E. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115755 · Cited by 46 · see citing works

Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition

Thiankhaw, K., Chattipakorn, K., Chattipakorn, S. C., & Chattipakorn, N. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130097 · Cited by 43 · see citing works

DNA-encoded chemical libraries of macrocycles

Connors, W. H., Hale, S. P., & Terrett, N. K. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.02.004 · Cited by 41 · see citing works

Ubiquitin Is a Novel Substrate for Human Insulin-Degrading Enzyme

Ralat, L. A., Kalas, V., Zheng, Z., Goldman, R. D., Sosnick, T. R., & Tang, W. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.026 · Cited by 40 · see citing works

Metallostasis and amyloid β-degrading enzymes

Grasso, G., Giuffrida, M. L., & Rizzarelli, E. (2012) · Metallomics · doi:10.1039/c2mt20105d · Cited by 40 · see citing works

Neprilysin Impedes Islet Amyloid Formation by Inhibition of Fibril Formation Rather Than Peptide Degradation*

Zraika, S., Aston-Mourney, K., Marek, P., Hull, R., Green, P., Udayasankar, J., Subramanian, S. L., Raleigh, D., & Kahn, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.082032 · Cited by 39 · see citing works

A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer’s Disease and Type 2 Diabetes Mellitus

Kaminari, A., Tsilibary, E. C., & Tzinia, A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180035 · Cited by 30 · see citing works

Crystal and Solution Structures of a Prokaryotic M16B Peptidase: an Open and Shut Case

Aleshin, A. E., Gramatikova, S. I., Hura, G. L., Bobkov, A. A., Strongin, A. Y., Stec, B., Tainer, J. A., Liddington, R., & Smith, J. W. (2009) · Structure · doi:10.1016/j.str.2009.09.009 · Cited by 38 · see citing works

Protective Role of Cys-178 against the Inactivation and Oligomerization of Human Insulin-degrading Enzyme by Oxidation and Nitrosylation

Ralat, L. A., Ren, M., Schilling, A. B., & Tang, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030627 · Cited by 38 · see citing works

Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues

Kochkina, E. G., Plesneva, S. A., Vasilev, D. S., Zhuravin, I. A., Turner, A. J., & Nalivaeva, N. N. (2015) · Biogerontology · doi:10.1007/s10522-015-9569-9 · Cited by 37 · see citing works

Structure Based Discovery of Small Molecules to Regulate the Activity of Human Insulin Degrading Enzyme

Çakır, B., Dağliyan, O., Dağyildiz, E., Barış, İ., Kavaklı, İ. H., Kızılel, S., & Türkay, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031787 · Cited by 37 · see citing works

Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis

Charton, J., Gauriot, M., Guo, Q., Hennuyer, N., Marechal, X., Dumont, J., Hamdane, M., Pottiez, V., Landry, V., Spérandio, O., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.009 · Cited by 36 · see citing works

Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease

Wang, W., Gopal, S., Pocock, R., & Xiao, Z. (2019) · Molecules · doi:10.3390/molecules24244604 · Cited by 35 · see citing works

Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease

Gough, M., Parr-Sturgess, C. A., & Parkin, E. T. (2010) · Biochemistry Research International · doi:10.1155/2011/721463 · Cited by 34 · see citing works

How our bodies fight amyloidosis: Effects of physiological factors on pathogenic aggregation of amyloidogenic proteins

Huang, L., Liu, X., Cheng, B., & Huang, K. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.01.007 · Cited by 34 · see citing works

The Origins of Specificity in the Microcin-Processing Protease TldD/E

Ghilarov, D., Serebryakova, M. V., Stevenson, C. E. M., Hearnshaw, S. J., Volkov, D. S., Maxwell, A., Lawson, D. M., & Severinov, K. (2017) · Structure · doi:10.1016/j.str.2017.08.006 · Cited by 34 · see citing works

The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme

de Tullio, M. B., Morelli, L., & Castaño, E. M. (2008) · Prion · doi:10.4161/pri.2.2.6710 · Cited by 34 · see citing works

The clearance of misfolded proteins in neurodegenerative diseases by zinc metalloproteases: An inorganic perspective

Malgieri, G., & Grasso, G. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.10.008 · Cited by 33 · see citing works

Effects of the gastric juice injection pattern and contraction frequency on the digestibility of casein powder suspensions in an in vitro dynamic rat stomach made with a 3D printed model

Zhang, X., Liao, Z., Wu, P., Chen, L., & Chen, X. D. (2018) · Food Research International · doi:10.1016/j.foodres.2017.12.082 · Cited by 32 · see citing works

A novel pectin from Polygala tenuifolia blocks Aβ42 aggregation and production by enhancing insulin-degradation enzyme and neprilysin

Zeng, H., Li, P., Zhou, L., & Ding, K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.212 · Cited by 32 · see citing works

Effects of safflower yellow on beta-amyloid deposition and activation of astrocytes in the brain of APP/PS1 transgenic mice

Shi, X., Zhang, H., Zhou, Z., Ruan, Y., Pang, J., Zhang, L., Zhai, W., & Hu, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.099 · Cited by 31 · see citing works

Intracellular FRET-based Screen for Redesigning the Specificity of Secreted Proteases

Guerrero, J. L., O'Malley, M. A., & Daugherty, P. S. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01051 · Cited by 29 · see citing works

Anti-Amnesic Effect of Walnut via the Regulation of BBB Function and Neuro-Inflammation in Aβ1-42-Induced Mice

Kim, J. M., Lee, U., Kang, J. Y., Park, S. K., Shin, E. J., Kim, H., Kim, C. W., Kim, M.-J., & Heo, H. J. (2020) · Antioxidants · doi:10.3390/antiox9100976 · Cited by 30 · see citing works

JD-30, an active fraction extracted from Danggui–Shaoyao–San, decreases β-amyloid content and deposition, improves LTP reduction and prevents spatial cognition impairment in SAMP8 mice

Hu, Z.-Y., Liu, G., Cheng, X., Huang, Y. Y., Yang, S., Shan-yi, Q., Sun, L., Zhou, W., & Zhang, Y. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.09.009 · Cited by 30 · see citing works

Impaired brain plasticity as a potential therapeutic target for treatment and prevention of dementia

Rajji, T. K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1550074 · Cited by 29 · see citing works

Structure–activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme

Charton, J., Gauriot, M., Totobenazara, J., Hennuyer, N., Dumont, J., Bosc, D., Marechal, X., Bakali, J. E., Herlédan, A., Wen, X., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.005 · Cited by 29 · see citing works

Alterations in mitochondria-endoplasmic reticulum connectivity in human brain biopsies from idiopathic normal pressure hydrocephalus patients

Leal, N. S., Dentoni, G., Schreiner, B., Kämäräinen, O., Partanen, N., Herukka, S., Koivisto, A. M., Hiltunen, M., Rauramaa, T. H., Leinonen, V., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0605-2 · Cited by 29 · see citing works

Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer’s disease

Liu, M., Guo, H., Li, C., Wang, D., Wu, J., Wang, C., Xu, J., & Ren-an, Q. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0906-y · Cited by 28 · see citing works

Nitric Oxide Decreases the Enzymatic Activity of Insulin Degrading Enzyme in APP/PS1 Mice

Kummer, M. P., Hülsmann, C., Hermes, M., Axt, D., & Heneka, M. T. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9339-7 · Cited by 26 · see citing works

Structures of Human CCL18, CCL3, and CCL4 Reveal Molecular Determinants for Quaternary Structures and Sensitivity to Insulin-Degrading Enzyme

Liang, W. G., Ren, M., Zhao, F., & Tang, W. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.01.012 · Cited by 26 · see citing works

High resolution crystal structure of substrate-free human neprilysin

Moss, S., Subramanian, V., & Acharya, K. R. (2018) · Journal of Structural Biology · doi:10.1016/j.jsb.2018.06.004 · Cited by 25 · see citing works

Insulin-Degrading Enzyme: Paradoxes and Possibilities

Leissring, M. A. (2021) · Cells · doi:10.3390/cells10092445 · Cited by 25 · see citing works

Characterization of plasma metal profiles in Alzheimer’s disease using multivariate statistical analysis

Guan, C., Dang, R., Cui, Y., Liu, L., Chen, X., Wang, X., Zhu, J., Li, D., Li, J., & Wang, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178271 · Cited by 26 · see citing works

Mechanisms of peptide and phosphoester hydrolysis catalyzed by two promiscuous metalloenzymes (insulin degrading enzyme and glycerophosphodiesterase) and their synthetic analogues

Hu, Q., Jayasinghe‐Arachchige, V. M., Sharma, G., Serafim, L. F., Paul, T. J., & Prabhakar, R. S. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1466 · Cited by 25 · see citing works

The solution of nitrogen inversion in amidases

Syrén, P. (2013) · FEBS Journal · doi:10.1111/febs.12241 · Cited by 23 · see citing works

Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review

Azam, M. S., Wahiduzzaman, M., Reyad‐ul‐Ferdous, M., Islam, M. N., & Roy, M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03237-7 · Cited by 23 · see citing works

Crystal structure of peptide‐bound neprilysin reveals key binding interactions

Moss, S., Subramanian, V., & Acharya, K. R. (2019) · FEBS Letters · doi:10.1002/1873-3468.13602 · Cited by 22 · see citing works

Target Enzymes Considered for the Treatment of Alzheimer’s Disease and Parkinson’s Disease

Kim, N., & Lee, H. J. (2020) · BioMed Research International · doi:10.1155/2020/2010728 · Cited by 21 · see citing works

Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer’s disease

Liu, H., & Le, W. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-7 · Cited by 21 · see citing works

Structural basis for the mechanisms of human presequence protease conformational switch and substrate recognition

Liang, W. G., Wijaya, J., Wei, H., Noble, A. J., Mancl, J. M., Mo, S., Lee, D. E., King, J. V. L., Pan, M., Liu, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29322-4 · Cited by 21 · see citing works

Distinct chemical factors in hydrolytic reactions catalyzed by metalloenzymes and metal complexes

Serafim, L. F., Jayasinghe‐Arachchige, V. M., Wang, L., Rathee, P., Yang, J., Moorkkannur, S. N., & Prabhakar, R. S. (2023) · Chemical Communications · doi:10.1039/d3cc01380d · Cited by 20 · see citing works

The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design

Tundo, G. R., Grasso, G., Persico, M., Tkachuk, O., Bellia, F., Bocedi, A., Marini, S., Parravano, M., Graziani, G., Fattorusso, C., et al. (2023) · Biomolecules · doi:10.3390/biom13101492 · Cited by 20 · see citing works

Structural changes in intermediate filament networks alter the activity of insulin‐degrading enzyme

Chou, Y.-H., Kuo, W.-L., Rosner, M. R., Tang, W., & Goldman, R. D. (2009) · The FASEB Journal · doi:10.1096/fj.09-137455 · Cited by 20 · see citing works

Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro

Shropshire, T. D., Reifert, J. R., Rajagopalan, S., Baker, D. A., Feinstein, S. C., & Daugherty, P. S. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0230 · Cited by 20 · see citing works

Stabilized β-Hairpin Peptide Inhibits Insulin Degrading Enzyme

Yang, D., Qin, W., Shi, X., Zhu, B., Xie, M., Zhao, H., Teng, B., Wu, Y., Zhao, R., Yin, F., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00418 · Cited by 19 · see citing works

Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases

Nakagawa, H., & Saito, Y. (2022) · Biology · doi:10.3390/biology11071017 · Cited by 19 · see citing works

Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer’s Disease and Aβ Plaque Management

Cerasuolo, M., Auriemma, M. C., Meo, I. D., Lenti, C., Papa, M., Paolisso, G., & Rizzo, M. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146693 · Cited by 18 · see citing works

Immunotherapy in Alzheimer’s disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline

Azargoonjahromi, A. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae066 · Cited by 17 · see citing works

The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension Management: A critical Update

Yasmin, S., Ashique, S., Taj, T., Garg, A. K., Das, J., Shorog, E., Bhui, U., Pal, R., Selim, S., Panigrahy, U. P., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149400 · Cited by 17 · see citing works

The influence of insulin infusion on the metabolism of amyloid β peptides in plasma

Karczewska‐Kupczewska, M., Lelental, N., Adamska, A., Nikołajuk, A., Kowalska, I., Górska, M., Zimmermann, R., Kornhuber, J., Strączkowski, M., & Lewczuk, P. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.013 · Cited by 17 · see citing works

Molecular basis of selective amyloid‐β degrading enzymes in Alzheimer's disease

Żukowska, J., Moss, S. J., Subramanian, V., & Acharya, K. R. (2023) · FEBS Journal · doi:10.1111/febs.16939 · Cited by 34 · see citing works

Elucidation of Interactions of Alzheimer Amyloid β Peptides (Aβ40 and Aβ42) with Insulin Degrading Enzyme: A Molecular Dynamics Study

Bora, R. P., & Prabhakar, R. S. (2010) · Biochemistry · doi:10.1021/bi1002103 · Cited by 16 · see citing works

Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization

Chesneau, V., Vekrellis, K., Rosner, M. R., & Selkoe, D. J. (2000) · Biochemical Journal · doi:10.1042/bj3510509 · Cited by 91 · see citing works

Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

Kurochkin, I. V., & Goto, S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00387-4 · Cited by 401 · see citing works

The Catalytic Domain of Insulin-degrading Enzyme Forms a Denaturant-resistant Complex with Amyloid β Peptide

Llovera, R. E., de Tullio, M. B., Alonso, L. G., Leissring, M. A., Kaufman, S. B., Roher, A. E., Gay, G. D. P., Morelli, L., & Castaño, E. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706316200 · Cited by 41 · see citing works